Advanced search
Publication Cover
Patient Preference and Adherence Volume 13, 2019 - Issue
Submit an article Journal homepage
304
Views
15
CrossRef citations to date
0
Altmetric
Review

Shared decision making for men facing prostate cancer treatment: a systematic review of randomized controlled trials

Nahara Anani Martínez-GonzálezInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, SwitzerlandCorrespondence[email protected]
,
Andreas PlateInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, Switzerland
,
Stefan MarkunInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, Switzerland
,
Oliver SennInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, Switzerland
,
Thomas RosemannInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, Switzerland
&
Stefan Neuner-JehleInstitute of Primary Care, University of Zurich and University Hospital of Zurich, ZurichCH-8091, Switzerland
Pages 1153-1174 | Published online: 17 Jul 2019

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
  • Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–1092. doi:10.1016/j.eururo.2012.02.05422424666
  • Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1):Cd004720.23440794
  • Donovan JL, Hamdy FC, Lane JA, et al. Patient-Reported Outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425–1437. doi:10.1056/NEJMoa160622127626365
  • Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi:10.1056/NEJMoa160622027626136
  • Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol. 2009;27(24):3916–3922. doi:10.1200/JCO.2008.18.648619620493
  • Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256. doi:10.1136/bmj.e25622286508
  • Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. doi:10.1007/s11606-012-2077-622618581
  • Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49(5):651–661.10452420
  • Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–629. doi:10.1016/j.eururo.2016.08.00327568654
  • Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v69–v77. doi:10.1093/annonc/mdv22226205393
  • Graham J, Kirkbride P, Cann K, Hasler E, Prettyjohns M. Prostate cancer: summary of updated NICE guidance. BMJ. 2014;348:f7524. doi:10.1136/bmj.f752424401467
  • Xiong T, Turner RM, Wei Y, Neal DE, Lyratzopoulos G, Higgins JP. Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis. BMJ Open. 2014;4(5):e004285. doi:10.1136/bmjopen-2013-004285
  • Martinez-Gonzalez NA, Plate A, Senn O, Markun S, Rosemann T, Neuner-Jehle S. Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials. Swiss Med Wkly. 2018;148:w14584. doi:10.4414/smw.2018.1457529473938
  • Egger M, Smith GD, Altman DG. Principles of and procedures for systematic reviews In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. 2nd ed. London (UK): BMJ Publishing Group; 2008:23–42.
  • Higgins JPT Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2009 [updated September 2011]. Available from: www.cochrane-handbook.org. Accessed March, 2018.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:10.1371/journal.pmed.100010019621070
  • Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–692.9032835
  • Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making. 2015;35(1):114–131. doi:10.1177/0272989X1455163825351843
  • Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d592822008217
  • Review Manager (RevMan) [Computer Program]. Version 5.3.5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014 Available from: http://community.cochrane.org/
  • Davison BJ, Goldenberg SL, Wiens KP, Gleave ME. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs. 2007;30(5):E7–E15. doi:10.1097/01.NCC.0000290819.22195.d617876177
  • Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology. 2007;16(6):543–552. doi:10.1002/pon.109416991107
  • Mishel MH, Germino BB, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009;77(3):349–359. doi:10.1016/j.pec.2009.09.00919819096
  • Davison BJ, Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs. 1997;20(3):187–196.9190093
  • Grossman DC, Curry SJ, Owens DK, et al. Screening for prostate cancer: US preventive services task force recommendation statement. JAMA. 2018;319(18):1901–1913. doi:10.1001/jama.2018.371029801017
  • Carlsson S, Leapman M, Carroll P, et al. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015;13:288. doi:10.1186/s12916-015-0526-x26612204
  • Bell N, Connor Gorber S, Shane A, et al. Recommendations on screening for prostate cancer with the prostate-specific antigen test. Can Med Assoc J. 2014;186(16):1225–1234. doi:10.1503/cmaj.14070325349003
  • Coulter A, Parsons S, Askham J. Health Systems and Policy Analysis. Policy Brief: Where are the Patients in Decision-Making about Their Own Care? Copenhagen (Denmark): European Observatory on Health Systems and Policies, WHO Regional Office for Europe; 2008.
  • Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419–426. doi:10.1016/j.juro.2013.04.11923659877
  • de Angst IB, Kil PJM, Bangma CH, Takkenberg JJM. Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer. J Geriatr Oncol. 2019. doi:10.1016/j.jgo.2018.12.003
  • Nazim SM, Fawzy M, Bach C, Ather MH. Multi-disciplinary and shared decision-making approach in the management of organ-confined prostate cancer. Arab J Urol. 2018;16(4):367–377. doi:10.1016/j.aju.2018.06.00830534434
  • Elwyn G, Frosch D, Rollnick S. Dual equipoise shared decision making: definitions for decision and behaviour support interventions. Implement Sci. 2009;4(1):75. doi:10.1186/1748-5908-4-7519922647

Reference

  • Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.